Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL445731 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL9100112 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL6692257 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL23152455 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL56814 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL23152453 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL338992 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL22323769 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL22323767 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL56813 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051583-A | Separator for zinc ion battery, method for preparing same, and zinc ion battery comprising same | 株式会社村田制作所 | 2026-05-15 | — | — | CN | claimed |
| US-20260135253-A1 | SEPARATOR FOR ZINC ION BATTERY, METHOD FOR PREPARING SAME, AND ZINC ION BATTERY INCLUDING SAME | MURATA MANUFACTURING CO (JP) | 2026-05-14 | — | — | US | claimed |
| CN-119607491-A | Battery fire extinguishing agent and preparation method and application thereof | 深圳普瑞赛思检测科技股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-117286071-B | Culture medium and culture method of Bacilluspastoris | 四川大学 | 2024-10-18 | — | — | CN | claimed |
| CN-118287117-A | Catalyst for preparing ethylenimine by intramolecular dehydration of monoethanolamine and preparation method thereof | 济南大学 | 2024-07-05 | — | — | CN | claimed |
| CN-117802526-B | Non-noble metal cathode hydrogen evolution catalyst for PEM (PEM) electrolyzed water and application thereof | 华电重工股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-117286071-A | Culture medium and culture method of Bacilluspastoris | 四川大学 | 2023-12-26 | — | — | CN | claimed |
| CN-116497367-A | Manganese dioxide nanowire network supported noble metal catalyst and preparation method thereof | 国家电投集团海南新能源投资有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-115676862-A | Two-stage process for removing silicon-containing minerals from bauxite | 中南大学 | 2023-02-03 | — | — | CN | claimed |
| CN-115125025-A | Biofuel oil and preparation method thereof | 青岛科技大学 | 2022-09-30 | — | — | CN | claimed |
| US-20050267592-A1 | DUAL FUNCTION PROSTHETIC BONE IMPLANT AND METHOD FOR PREPARING THE SAME | JIIN-HUEY CHERN LIN (US) | 2005-12-01 | — | — | US | claimed |
| WO-2005079880-A1 | METHODS FOR PREPARING MEDICAL IMPLANTS FROM CALCIUM PHOSPHATE CEMENT AND MEDICAL IMPLANTS | CALCITEC, INC. (US) | 2005-09-01 | — | — | WO | claimed |
| US-20050186353-A1 | Method for making a porous calcium phosphate article | CALCITEC, INC. | 2005-08-25 | — | — | US | claimed |
| US-20050184417-A1 | METHOD FOR MAKING A POROUS CALCIUM PHOSPHATE ARTICLE | CANA LAB CORPORATION (TW) | 2005-08-25 | — | — | US | claimed |
| US-20050184418-A1 | Method for making a porous calcium phosphate article | CALCITEC, INC. | 2005-08-25 | — | — | US | claimed |
| US-20050076813-A1 | Process for producing fast-setting, bioresorbable calcium phosphate cements | CALCITEC, INC. | 2005-04-14 | — | — | US | claimed |
| WO-2005016616-A1 | METHODS FOR PREPARING MEDICAL IMPLANTS FROM CALCIUM PHOSPHATE CEMENT AND MEDICAL IMPLANTS | CALCITEC, INC. (US) | 2005-02-24 | — | — | WO | claimed |
| US-20050029701-A1 | Method for making a molded calcium phosphate article | CANA LAB CORPORATION (TW) | 2005-02-10 | — | — | US | claimed |
| US-6840995-B2 | Process for producing fast-setting, bioresorbable calcium phosphate cements | CALCITEC, INC. (US) | 2005-01-11 | — | — | US | claimed |
| US-20030121450-A1 | Process for producing fast-setting, bioresorbable calcium phosphate cements | JIIN-HUEY CHERN LIN | 2003-07-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260135253-A1 | SEPARATOR FOR ZINC ION BATTERY, METHOD FOR PREPARING SAME, AND ZINC ION BATTERY INCLUDING SAME | SLC39A3, FYN, SLC39A11 | CA2 713/4885SLC34A1 113/4885KDM4E 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.